Cargando…

Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly

The aim of this study was to assess the effects of replacement with recombinant human growth hormone (rhGH) in patients with GH deficiency (GHD) after treatment of acromegaly. Intervention study. Sixteen patients (8 men, age 56 years), treated for acromegaly by surgery and radiotherapy, with an insu...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Klaauw, Agatha A., Bax, Jeroen J., Roelfsema, Ferdinand, Stokkel, Marcel P. M., Bleeker, Gabe B., Biermasz, Nienke R., Smit, Johannes W. A., Romijn, Johannes A., Pereira, Alberto M.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764055/ https://www.ncbi.nlm.nih.gov/pubmed/19521779 http://dx.doi.org/10.1007/s11102-009-0186-y

Ejemplares similares

Nanomedicines in the treatment of acromegaly: focus on pegvisomant
por: Roelfsema, Ferdinand, et al.
Publicado: (2006)

Therapeutic options in the management of acromegaly: focus on lanreotide Autogel(®)
por: Roelfsema, Ferdinand, et al.
Publicado: (2008)

Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients
por: Biermasz, Nienke R., et al.
Publicado: (2007)

Pituitary-hormone secretion by thyrotropinomas
por: Roelfsema, Ferdinand, et al.
Publicado: (2008)

The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomas
por: Kokshoorn, Nieke E., et al.
Publicado: (2011)

Treatment of Acromegaly: Are We Satisfied With the Current Outcome?
por: Roelfsema, Ferdinand
Publicado: (2014)

State of the Art of Patient-reported Outcomes in Acromegaly or GH Deficiency: A Systematic Review and Meta-analysis
por: van der Meulen, Merel, et al.
Publicado: (2021)

SAT-440 Modulating Effects of Progesterone on Spontaneous and Ghrelin-Induced GH Secretion in Postmenopausal Women
por: Roelfsema, Ferdinand, et al.
Publicado: (2019)

How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review
por: van Esdonk, Michiel J., et al.
Publicado: (2018)

Difficulties in diagnosing acromegaly, acromegaly with apparently normal GH: Micromegaly
por: Demir, Ahmet Numan, et al.
Publicado: (2023)

Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience
por: Dutta, Pinaki, et al.
Publicado: (2015)

Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis
por: Roelfsema, Ferdinand, et al.
Publicado: (2011)

Neurocognitive Function in Acromegaly after Surgical Resection of GH-Secreting Adenoma versus Naïve Acromegaly
por: Martín-Rodríguez, Juan Francisco, et al.
Publicado: (2013)

Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly
por: Cardinal, Tyler, et al.
Publicado: (2021)

Atypical Course of a Patient With AIP-Positive Acromegaly: From GH Excess to GH Deficiency and Back to GH Excess
por: García-de-la-Torre, Keren-Sandyn, et al.
Publicado: (2023)

Clinical and radiographic assessment of peripheral joints in controlled acromegaly
por: Pelsma, Iris C. M., et al.
Publicado: (2022)

Head-and-neck paragangliomas are associated with sleep-related complaints, especially in the presence of carotid body tumors
por: Havekes, Bas, et al.
Publicado: (2011)

Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters
por: Geraedts, Victor J., et al.
Publicado: (2017)

GH Secretory Dynamics and Responsiveness to SMS 201-995 Treatment in Acromegaly
por: Kim, Sung Woon, et al.
Publicado: (1988)

Low sclerostin levels after long-term remission of acromegaly
por: Claessen, Kim M. J. A., et al.
Publicado: (2021)

Is GH Replacement for Adult GH Deficiency Safe?
por: Melmed, Shlomo
Publicado: (2022)

Effects of Toremifene, a Selective Estrogen Receptor Modulator, on Spontaneous and Stimulated GH Secretion, IGF-I, and IGF-Binding Proteins in Healthy Elderly Subjects
por: Roelfsema, Ferdinand, et al.
Publicado: (2017)

Limitations of Tc99m-MIBI-SPECT Imaging Scans in Persistent Primary Hyperparathyroidism
por: Witteveen, Janneke E., et al.
Publicado: (2010)

GH, IGF-1, and Age Are Important Contributors to Thyroid Abnormalities in Patients with Acromegaly
por: Wu, Xia, et al.
Publicado: (2018)

Surgical Remission of Acromegaly Resolves Neuroglycopenia and Paradoxical Rise in GH after OGTT
por: Magar, Maria, et al.
Publicado: (2021)

GH Receptor Exon 3 Genotype and Echocardiographic Abnormalities in Patients With Active Acromegaly
por: Serrano, Karla, et al.
Publicado: (2021)

THU483 Role Of Excess GH On Breast Cancer Aggressiveness And Metastasis In Acromegaly
por: Hun, Ju, et al.
Publicado: (2023)

Both Transient and Continuous Corticosterone Excess Inhibit Atherosclerotic Plaque Formation in APOE*3-Leiden.CETP Mice
por: Auvinen, Hanna E., et al.
Publicado: (2013)

Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma
por: Dekkers, O. M., et al.
Publicado: (2007)

Left ventricular dyssynchrony assessed by two three-dimensional imaging modalities: phase analysis of gated myocardial perfusion SPECT and tri-plane tissue Doppler imaging
por: Ajmone Marsan, Nina, et al.
Publicado: (2007)

Improvement in Symptoms and Health-Related Quality of Life in Acromegaly Patients: A Systematic Review and Meta-Analysis
por: Broersen, Leonie H A, et al.
Publicado: (2020)

Impact of Growth Hormone (GH) Deficiency and GH Replacement upon Thymus Function in Adult Patients
por: Morrhaye, Gabriel, et al.
Publicado: (2009)

Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy
por: Bona, C., et al.
Publicado: (2022)

Growth Hormone Secretion Does Not Increase After Interleukin-2 Administration in Healthy Men
por: Roelfsema, Ferdinand, et al.
Publicado: (2021)

Thyrotoxicosis with absence of clinical features of acromegaly in a TSH- and GH-secreting, invasive pituitary macroadenoma
por: Johnston, Philip C, et al.
Publicado: (2015)

Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly
por: van Trigt, Victoria R., et al.
Publicado: (2021)

Glucocorticoid excess induces long-lasting changes in body composition in male C57Bl/6J mice only with high-fat diet
por: Auvinen, Hanna E, et al.
Publicado: (2013)

Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant
por: Strasburger, Christian J, et al.
Publicado: (2018)

GH Replacement in the Elderly: Is It Worth It?
por: Ricci Bitti, Silvia, et al.
Publicado: (2021)

Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH Deficiency
por: Kohno, Hitoshi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rtuh63pijk97c9mjargdk4e3s7